INTERNATIONAL PATENT: PRISETREE INTELLIGENT DRUGS, INC., 上海欣药智能科技有限公司 FILES APPLICATION FOR "INHALABLE PHARMACEUTICAL COMPOSITION CONTAINING SOLUBLE GUANYLATE CYCLASE RECEPTOR AGONIST, USE THEREOF AND TREATMENT METHOD FOR PULMONARY HYPERTENSION"

Posted On: 2026-03-29

GENEVA, March 29 -- PRISETREE INTELLIGENT DRUGS, INC. (Room 213, Zhangjiang Entrepreneurial Workshop, No. 800Huanhu West Second Road, Lingang New City, Pudong New AreaShanghai 201306), 上海欣药智能科技有限公司 (中国上海市浦东新区临港新城环湖西二路800号张江创业工坊213室) filed a patent application (PCT/CN2025/123226) for "INHALABLE PHARMACEUTICAL COMPOSITION CONTAINING SOLUBLE GUANYLATE CYCLASE RECEPTOR AGONIST, USE THEREOF, AND TREATMENT METHOD FOR PULMONARY HYPERTENSION" on Sep 23, 2025. With publication no. WO/2026...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: PRISETREE INTELLIGENT DRUGS, INC., 上海欣药智能科技有限公司 FILES APPLICATION FOR "INHALABLE PHARMACEUTICAL COMPOSITION CONTAINING SOLUBLE GUANYLATE CYCLASE RECEPTOR AGONIST, USE THEREOF AND TREATMENT METHOD FOR PULMONARY HYPERTENSION"